GRANDPHARMA

512
4.3400.58% ( +0.025 )
Delay Closed: Nov 16, 16:08:11

Overview

GRANDPHARMA (512)

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations...

Open
4.330
High
4.415
Low
4.290
Prev. Close
4.315
Volume
4.64M
Turnover
20.20M
Avg Price
4.354
Bid/Ask Ratio
-90.00%
Amplitude
2.90%
52wk High
8.671
Volume Ratio
0.85
Turnover Ratio
0.13%
52wk Low
4.135
HK Mkt Cap
15.41B
Market CapHKD
15.41B
P/ETTM
13.89
P/EDynamic
7.26
P/EStatic
--
EPSTTM
0.313
EPSDynamic
0.598
EPSStatic
--
BVPS
4.86
P/B
0.89
HK Shares
3.55B
Dividend YieldTTM
3.89%
DividendTTM
0.169
Shares
3.55B
Min lot size
500
Currency
HKD

GRANDPHARMA Analyst Rating

View more

Forecast & Rating

Sep 8, 2026
Price forecast
HK$9.53119.51%
Forecast & RatingStrong buy
4analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Jul, 2

    远大医药 (512.HK) 今日大涨 8.7%,因肝癌创新药 DOORwaY90 试验结果积极,叠加公司获 8 亿港元贷款稳定股权结构。盘中低开于 4.940 港元后单边上行,午后触及 5.140 港元日高,收盘 5.110 港元,距 52 周低点 4.53 港元回升 12.8%,但较 52 周高点 9.89 港元仍跌 48.3%,且低于 MA60 的 5.764 港元。2025 年 Q4 营收同比增 10.3% 至 30.88 亿港元,但净利润暴跌 92.1% 至 3593 万港元,净利率仅 1.16%。PE14.6 倍、PB1.07 倍,股息率 3.31%。不过,前期利润预警及股价 YTD 跌 34.5% 仍构成压力。

News